According to Lyell Immunopharma's latest financial reports the company's current earnings (TTM) are -HK$1.64 B. In 2023 the company made an earning of -HK$1.83 B a decrease over its 2022 earnings that were of -HK$1.43 B.The earnings displayed on this page is the company's Pretax Income.